Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
J Nutr. 2024 Oct;154(10):3019-3030. doi: 10.1016/j.tjnut.2024.08.005. Epub 2024 Aug 10.
Prior research has highlighted inverse associations between concentrations of circulating very long-chain saturated fatty acids (VLCSFAs) and coronary artery disease (CAD). However, the intricate links involving VLCSFAs, gut microbiota, and bile acids remain underexplored.
This study examined the association of erythrocyte VLCSFAs with CHD incidence, focusing on the mediating role of gut microbiota and fecal bile acids.
This 10-y prospective study included 2383 participants without CHD at baseline. Erythrocyte VLCSFAs [arachidic acid (C20:0), behenic acid (C22:0), and lignoceric acid (C24:0)] were measured using gas chromatography at baseline, and 274 CHD incidents were documented in triennial follow-ups. Gut microbiota in 1744 participants and fecal bile acid metabolites in 945 participants were analyzed using 16S ribosomal ribonucleic acid sequencing and ultra-performance liquid chromatography-tandem mass spectrometry at middle-term.
The multivariable-adjusted hazard ratios (95% confidence interval) for CHD incidence in highest compared with lowest quartiles were 0.87 (0.61, 1.25) for C20:0, 0.63 (0.42, 0.96) for C22:0, 0.59 (0.41, 0.85) for C24:0, and 0.57 (0.39, 0.83) for total VLCSFAs. Participants with higher total VLCSFA concentrations exhibited increased abundances of Holdemanella, Coriobacteriales Incertae Sedis spp., Ruminococcaceae UCG-005 and UCG-010, and Lachnospiraceae ND3007 group. These 5 genera generated overlapping differential microbial scores (ODMSs) that accounted for 11.52% of the total VLCSFAs-CHD association (P = 0.018). Bile acids tauro_α_ and tauro_β_muricholic acid were inversely associated with ODMS and positively associated with incident CHD. Opposite associations were found for glycolithocholic acid and glycodeoxycholic acid. Mediation analyses indicated that glycolithocholic acid, glycodeoxycholic acid, and tauro_α_ and tauro_β_muricholic acid explained 56.40%, 35.19%, and 26.17% of the ODMS-CHD association, respectively (P = 0.002, 0.008, and 0.020).
Elevated erythrocyte VLCSFAs are inversely associated with CHD risk in the Chinese population, with gut microbiota and fecal bile acid profiles potentially mediating this association. The identified microbiota and bile acid metabolites may serve as potential intervention targets in future studies. This trial was registered at www.
gov as NCT03179657.
先前的研究强调了循环中长链饱和脂肪酸(VLCSFAs)浓度与冠心病(CAD)之间的反比关系。然而,VLCSFAs、肠道微生物群和胆汁酸之间的复杂联系仍未得到充分探索。
本研究旨在探讨红细胞 VLCSFAs 与 CHD 发病风险之间的关联,并重点研究肠道微生物群和粪便胆汁酸的中介作用。
本前瞻性研究纳入了基线时无 CHD 的 2383 名参与者。使用气相色谱法在基线时测量红细胞 VLCSFAs[花生酸(C20:0)、山嵛酸(C22:0)和二十四烷酸(C24:0)],并在为期 3 年的随访中记录了 274 例 CHD 事件。使用 16S 核糖体 RNA 测序和超高效液相色谱-串联质谱法分别对 1744 名参与者的肠道微生物群和 945 名参与者的粪便胆汁酸代谢物进行了分析。
最高四分位组与最低四分位组相比,CHD 发病风险的多变量调整后危险比(95%置信区间)分别为 C20:0 为 0.87(0.61,1.25)、C22:0 为 0.63(0.42,0.96)、C24:0 为 0.59(0.41,0.85)和总 VLCSFAs 为 0.57(0.39,0.83)。总 VLCSFA 浓度较高的参与者具有较高的 Holdemanella、Coriobacteriales Incertae Sedis spp.、Ruminococcaceae UCG-005 和 UCG-010 以及 Lachnospiraceae ND3007 组的丰度。这 5 个属产生了重叠的差异微生物评分(ODMS),占总 VLCSFAs-CHD 关联的 11.52%(P=0.018)。牛磺-α-和牛磺-β-熊去氧胆酸与 ODMS 呈负相关,与 CHD 发病呈正相关。而甘氨胆酸和甘脱氧胆酸则表现出相反的关联。中介分析表明,甘氨胆酸、甘脱氧胆酸和牛磺-α-和牛磺-β-熊去氧胆酸分别解释了 ODMS-CHD 关联的 56.40%、35.19%和 26.17%(P=0.002、0.008 和 0.020)。
中国人群中红细胞 VLCSFAs 水平升高与 CHD 风险呈负相关,肠道微生物群和粪便胆汁酸谱可能介导了这种关联。鉴定出的微生物群和胆汁酸代谢物可能成为未来研究的潜在干预靶点。本试验在中国临床试验注册中心注册,注册号为 NCT03179657。